Current Recommendations for the Prevention and Treatment of Influenza in the Older Population
- 6 Downloads
Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be encouraged. Prophylactic amantadine 100 mg/day should be given for 2 weeks with influenza vaccine in the aged population when they have not been previously immunised. Broad application of these preventive measures would have a significant impact on reducing influenza prevalence in the elderly and other high risk groups.
KeywordsInfluenza Influenza Virus Influenza Vaccine Amantadine Rimantadine
Unable to display preview. Download preview PDF.
- Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In Kendal AP & Patriarca PA (Eds) Options for the control of influenza, pp. 155–158, Alan R. Liss, New York, 1986Google Scholar
- Barker WM, Mullooly JP. Effectiveness of inactivated influenza vaccine among non-institutionalized elderly persons. In Kendal AP & Patriarca PA (Eds) Options for the control of influenza, pp. 169–182, Alan R. Liss, New York, 1986Google Scholar
- Buchner DM, Larson EB, White RF. Influenza vaccination in community elderly: a controlled trial of postcard reminders. Journal of the American Geriatric Society 35: 755–760, 1987Google Scholar
- Gate TR. Clinical manifestations and consequences of influenza. American Journal of Medicine 82(6A): 15–19, 1987Google Scholar
- Douglas Jr RG. Antimicrobial agents: antiviral agents. In Goodman and Gilman (Eds) The pharmacological basis of therapeutics, 8th ed., pp. 1182–1201, Pergamon Press, New York, 1990Google Scholar
- Fedson DS. Immunizations for health care workers and patients in hospitals. In Wenzel RP (Ed.) Prevention and control of nosocomial infections, pp. 116–174, Williams & Wilkins, Baltimore, 1987Google Scholar
- Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. Journal of the American Geriatric Society 33: 269–272, 1985Google Scholar
- Grabowski N, May JJ, Pratt DS, Richtsmeier WJ, Bertino JS. The effect of split virus influenza vaccination on theophylline pharmacokinetics. American Review of Respiratory Diseases 131: 934–983, 1985Google Scholar
- Gross PA, Quinnan Jr GV, Weksler ME, Gaerlan PF, Denning CR. Immunization of elderly people with high doses of influenza vaccine. Journal of the American Geriatric Society 36: 209–212, 1988bGoogle Scholar
- Phair J, Kaufman CA, Bjoruson A, Adams L, Iinneman Jr C. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. Journal of Laboratory and Clinical Medicine 92: 882–888, 1978Google Scholar
- Recommendations of the Immunization Practices Advisory Committee (ACIP). Prevention and control of influenza. And addendum clarification. Morbidity and Mortality Weekly Report 39(RR-7): 1–15, 1990 Morbdity and Mortality Weekly Report 39: 469, 1990Google Scholar